Jefferies Group LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Jefferies Group LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Sep 21, 2023	BUY	$7.7 - $37.13 $100,870 - $486,403	13,100 Added 65.5%	33,100 $323,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $100,870 - $486,403	13,100 Added 65.5%	33,100 $323,000
Q3 2021 Sep 21, 2023	SELL	$26.46 - $37.15 $1.11 Million - $1.56 Million	-42,000 Reduced 67.74%	20,000 $679,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $1.11 Million - $1.56 Million	-42,000 Reduced 67.74%	20,000 $680,000
Q2 2021 Sep 21, 2023	BUY	$32.73 - $47.95 $654,599 - $959,000	20,000 Added 47.62%	62,000 $2.27 Million
Q2 2021 Aug 20, 2021	SELL	$32.73 - $47.95 $201 Million - $294 Million	-6,138,000 Reduced 99.0%	62,000 $2.27 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $202 Million - $295 Million	6,158,000 Added 14661.9%	6,200,000 $2.27 Million
Q1 2021 Sep 21, 2023	BUY	$40.39 - $56.73 $908,775 - $1.28 Million	22,500 Added 115.38%	42,000 $1.88 Million
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $908,775 - $1.28 Million	22,500 Added 115.38%	42,000 $1.88 Million
Q4 2020 Sep 21, 2023	BUY	$51.77 - $66.18 $1.01 Million - $1.29 Million	19,500 New	19,500 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $127,019 - $168,664	2,900 Added 17.47%	19,500 $1 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $1.23 Million - $2.17 Million	-33,300 Reduced 66.73%	16,600 $991,000
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $669,237 - $1.38 Million	19,900 Added 66.33%	49,900 $2.05 Million
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $951,000 - $2.1 Million	30,000 New	30,000 $1.87 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.